Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng Gee Lim

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
Antiviral Therapy|April 28, 2006
A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BSeng Gee Lim, Chun-too Wai, Yin Mei Lee, et al.
Journal of Clinical Gastroenterology|September 14, 2016
World Gastroenterology Organisation Global Guideline Hepatitis B: September 2015Jordan Feld, Harry L A Janssen, Zaigham Abbas, et al.
World Journal of Hepatology|January 14, 2021
Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese populationGuan Huei Lee, Wah Wah Phyo, Wai Mun Loo, et al.
Archives of Internal Medicine|January 13, 2006
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BSeng Gee Lim, Tay Meng Ng, Nelson Kung, et al.
World Journal of Hepatology|July 12, 2019
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infectionEn Xian Sarah Low, Edhel Tripon, Kieron Lim, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 19, 2020
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized TherapyDaniel Q Huang, Mark D Muthiah, Lei Zhou, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of TreatmentGrace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
Journal of Gastroenterology and Hepatology|August 12, 2004
Practical difficulties in the management of hepatitis B in the Asia-Pacific regionRosmawati Mohamed, Paul Desmond, Dong-Jin Suh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2024
Single-cell RNA sequencing reveals anti-tumor potency of CD56<sup>+</sup> NK cells and CD8<sup>+</sup> T cells in humanized mice via PD-1 and TIGIT co-targetingWai Nam Liu, Sarah L Harden, Shawn Lu Wen Tan, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
Antiviral Therapy|April 28, 2006
A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BSeng Gee Lim, Chun-too Wai, Yin Mei Lee, et al.
Journal of Clinical Gastroenterology|September 14, 2016
World Gastroenterology Organisation Global Guideline Hepatitis B: September 2015Jordan Feld, Harry L A Janssen, Zaigham Abbas, et al.
World Journal of Hepatology|January 14, 2021
Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese populationGuan Huei Lee, Wah Wah Phyo, Wai Mun Loo, et al.
Archives of Internal Medicine|January 13, 2006
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BSeng Gee Lim, Tay Meng Ng, Nelson Kung, et al.
World Journal of Hepatology|July 12, 2019
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infectionEn Xian Sarah Low, Edhel Tripon, Kieron Lim, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 19, 2020
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized TherapyDaniel Q Huang, Mark D Muthiah, Lei Zhou, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of TreatmentGrace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
Journal of Gastroenterology and Hepatology|August 12, 2004
Practical difficulties in the management of hepatitis B in the Asia-Pacific regionRosmawati Mohamed, Paul Desmond, Dong-Jin Suh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2024
Single-cell RNA sequencing reveals anti-tumor potency of CD56<sup>+</sup> NK cells and CD8<sup>+</sup> T cells in humanized mice via PD-1 and TIGIT co-targetingWai Nam Liu, Sarah L Harden, Shawn Lu Wen Tan, et al.
Pageof 25